CMS Open Payments · Program Year 2024
Ellex, Inc
Ellex, Inc reported $41,648.59 across General Payments, Research, and Ownership to 41 physicians and teaching hospitals across 41 transactions.
- $41.6K Below-median payer
- All-tracks total
- 41 Below-median volume
- Transactions
- 41 Below-median reach
- Recipients
- #1397
- of 1,925 companies
Ellex, Inc reported $41,648.59 across all CMS Open Payments tracks (General + Research + Ownership) to 41 physicians and teaching hospitals in Program Year 2024 - ranking #1397 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $41,648.59, averaging $1.0K per recipient.
Ellex, Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer ellex-inc Ellex, Inc
$41.6K · #1397/1,925 · 0.0% industry · PY2024
- TOT $41.6K
- RANK #1397
- SHARE 0.0%
- TXN 41
- RCP 41
- CAT 1
- GEN $41.6K
- TOP1 64.8%
- PY 2024
Volume peers
Nearest volume peer: OPHTEC USA, Inc. ($41.7K)
Ellex, Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Ellex, Inc
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Ellex, Inc that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 1 general-payment categories charted below, "Food and Beverage" is the largest at $41.6K across 41 transactions, 100.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Food and Beverage" leads Ellex, Inc's 1-category general-payment breakdown at $41.6K, 100.0% of the reported total.
How Ellex, Inc divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $41.6K | 41 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $39,578.23 (95.0%) of $41,648.59 in this company's General Payments records across 24 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Ellex, Inc
The five named recipients with the highest reported General Payments from this company
- 1
Inder Paul Singh
$27,000.00 across 2 reported transactions
- 2
Nathan Lighthizer
$7,607.87 across 2 reported transactions
- 3
Larissa Camejo
$3,062.50 across 2 reported transactions
- 4
Taj-Addin Nasser
$1,250.00 across 1 reported transactions
- 5
Rolando Toyos
$657.86 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Ellex, Inc ranks #1397 of 1,925 by total payments (bottom 27% by spend) but is notably more concentrated than that alone would suggest -- #398 of 1,838 by HHI (top 22% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- EMD Millipore Corporation : $47.0K total payments, HHI 4713
- SunMed Group Holdings, LLC : $60.3K total payments, HHI 4712
- Techfit Digital Surgery Inc : $1.7K total payments, HHI 4709
- Advanced Sterilization Products Services Inc. : $76.1K total payments, HHI 4696
- Polymedco, LLC : $17.5K total payments, HHI 4621
- McKesson Drug Company LLC : $30.7K total payments, HHI 4613
- Ellex, Inc (this company) : $41.6K total payments, HHI 4605
- Haag-Streit USA, Inc. : $195.6K total payments, HHI 4605
- NeuraSignal Inc. : $8.3K total payments, HHI 4575
- Heru, Inc. : $11.0K total payments, HHI 4571
- Actuated Medical, Inc. : $8.0K total payments, HHI 4564
- Fisher & Paykel Healthcare Limited : $81.6K total payments, HHI 4558
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Ellex, Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Ellex, Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Ellex, Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Olympus Latin America, Inc.
Bonebridge Inc.
Samsung Medison Co., Ltd.
Signature Orthopaedics USA Corp
Mozarc Medical US LLC
Put this to use
Ellex, Inc ranks #1397 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Ellex, Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.